Movement toward personalised medicine gains momentum In 2010, at a TEDMED event, Thomas Goetz said that “in healthcare, decision-making isn’t a science problem, it’s an information problem!” For [...]
VC Deals Apitope, a Belgium-based drug developer focused on “treating the underlying cause of autoimmune diseases,” has raised €12 million in Series B funding.Wales Life Sciences Fund led the [...]
VC Deals Deciphera Pharmaceuticals, a Waltham, Mass.-based developer of kinase inhibitor treatments targeting tumors cells, has raised $75 million in Series B funding led by New Leaf Venture [...]
VC Deals Mechio Inc. (dba Motiv), a San Francisco-based micro-wearables startup, has raised more than $8.6 million in Series A funding, according to a regulatory filing. Kleiner Perkins Caufield [...]
http://www.forbes.com/sites/unitystoakes/2015/08/01/the-leapfrog-opportunity-in-the-worlds-underserved-health-care-markets/?utm_source=StartUp Health [...]
VC Deals Selecta Biosciences Inc., a Watertown, Mass.-based developer of targeted antigen-specific immune therapies, has raised $38 million in Series E funding. Existing shareholder OrbiMed [...]
VC Deals CeQur SA, a Swiss developer of insulin infusion solutions for people with diabetes, has raised $100 million in Series C funding. Woodford Investment Management and Arthurian Life [...]
VC Deals Editas Medicine, a Cambridge, Mass.-based genome editing company, has raised $120 million in Series B funding. Boris Nikolic led the round, on behalf of a U.S. investment company formed [...]
VC Deals LifeBond, an Israel-based developer of surgical sealants, has raised $27 million in Series D funding. Backers include Adams Street Partners, Sino Biopharmaceutical and return backers [...]
http://theinnovationandstrategyblog.com/innovation/innovation-and-sales/julien-de-salaberrys-innovation-overcome-affordability-barrier-emerging-markets